Peter Bettelheim

Linz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Implementation of a one-tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine.

Implementation of a one-tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine.

Journal: Cytometry. Part B, Clinical cytometry

Published: December 11, 2024

BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.

BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.

Journal: American journal of hematology

Published: January 30, 2024

CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.

CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.

Journal: Leukemia

Published: May 02, 2023

Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.

Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.

Journal: American journal of hematology

Published: November 30, 2022

Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group.

Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group.

Journal: Cytometry. Part B, Clinical cytometry

Published: January 30, 2022

PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.

PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.

Journal: American journal of hematology

Published: November 29, 2021

Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.

Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.

Journal: Cytometry. Part B, Clinical cytometry

Published: September 29, 2021

Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.

Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.

Journal: Cytometry. Part B, Clinical cytometry

Published: July 09, 2021

ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry.

ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry.

Journal: Cytometry. Part B, Clinical cytometry

Published: July 09, 2021

Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.

Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.

Journal: Cytometry. Part B, Clinical cytometry

Published: July 01, 2021

Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.

Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.

Journal: Neoplasia (New York, N.Y.)

Published: June 25, 2021

Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.

Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.

Journal: European journal of haematology

Published: March 02, 2021

Showing 1-12 of 32

Last Updated: 09/26/2026